|
Volumn 61, Issue 105 S, 1982, Pages 37-40
|
Effects of the Estrogenicity of Levonorgestrel/Ethinylestradiol Combinations on the Lipoprotein Status
a,b a,b a,b a,b |
Author keywords
[No Author keywords available]
|
Indexed keywords
CHOLESTEROL;
ETHINYLESTRADIOL;
LEVONORGESTREL;
LIPOPROTEIN;
NORGESTREL;
ORAL CONTRACEPTIVE AGENT;
PHOSPHOLIPID;
SEX HORMONE BINDING GLOBULIN;
TRIACYLGLYCEROL;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
SEX HORMONE BINDING PROTEIN;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
COMPARATIVE STUDY;
FEMALE;
HUMAN;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
BLOOD AND HEMOPOIETIC SYSTEM;
CONTROLLED STUDY;
ENDOCRINE SYSTEM;
FEMALE GENITAL SYSTEM;
HUMAN CELL;
LIPID BLOOD LEVEL;
LIPID METABOLISM;
NORMAL HUMAN;
ORAL CONTRACEPTION;
ORAL DRUG ADMINISTRATION;
PREGNANCY;
PREVENTION;
CHOLESTEROL;
CLINICAL TRIALS;
COMPARATIVE STUDY;
CONTRACEPTIVES, ORAL;
CONTRACEPTIVES, ORAL, COMBINED;
CONTRACEPTIVES, ORAL, SYNTHETIC;
ETHINYL ESTRADIOL;
FEMALE;
HUMAN;
LEVONORGESTREL;
LIPOPROTEINS;
NORGESTREL;
PHOSPHOLIPIDS;
RANDOM ALLOCATION;
SEX HORMONE-BINDING GLOBULIN;
TRIGLYCERIDES;
|
EID: 0020010166
PISSN: 00016349
EISSN: 16000412
Source Type: Journal
DOI: 10.3109/00016348209155316 Document Type: Article |
Times cited : (25)
|
References (6)
|